Medical Devices Industry Reports Programmable Infusion Pumps and Catheters Market | Page 2

REPORT DESCRIPTION
Programmable Infusion Pumps and Catheters Market – Overview
Frequent approvals of novel infusion pumps and their launches in developed economies are expected to
significantly drive the global programmable infusion pumps and catheters market growth over the forecast period.
For instance, in April 2018, Smiths Group plc. launched its new product, CADD-Solis wireless infusion pump, for
safe delivery of analgesics. These infusion pumps are portable and have wireless software and drug library
updation facility without the need to find, plug in and update the pump personally.
In April 2013, Flowonix Medical Inc., a medical device company involved in the manufacture of implantable drug
delivery systems, launched the Prometra programmable intrathecal pump in the U.S. The pump is implantable and
effective in delivering Infumorp (preservative free morphine) in patients undergoing treatment for chronic pain as
it directly delivers the medication in the intrathecal space around the spinal cord. The Prometra pump uses a dual-
gated valve drug delivery mechanism for accurate dosing.
The global programmable infusion pumps and catheters market was valued at US$ 8,365.3 million in 2017, and is
expected to witness a robust CAGR of 5.8% over the forecast period (2018–2026).